The OrganoTherapeutics team is very excited to announce that we have been accepted in the 2020 cohort of the MassChallenge program. We will be part of the MassChallenge Texas cohort in Houston.
We particularly thank the University of Luxembourg and the University of Luxembourg Incubator for their continuous support. Furthermore, we want to acknowledge that these achievements are based on academic work that has been funded by the FNR in Luxembourg.
Here is the press release from MassChallenge: https://masschallenge.org/announcement/masschallenge-texas-in-houston-announces-first-summer-cohort